DALLAS--(BUSINESS WIRE)--ActivePure Medical, a division of AP Sciences Group, LLC, a global provider of cutting-edge, continuous air and surface decontamination technology for healthcare, today announced that its Chief Medical & Science Advisor, Dr. Deborah Birx, will participate in an exclusive fireside chat at an event hosted today by The Health Management Academy (THMA). Dr. Birx will also participate in a second fireside chat at a THMA event in October. THMA is a leading community of executives from top U.S. health systems and other innovative industry companies, cultivating relationships and addressing critical industry issues since 1998. These high-profile engagements underscore ActivePure Medical's commitment to advancing healthcare innovation and infection control strategies.
Event Details:
Fall 2024 Value Based Strategy Collaborative
Date: Monday, September 9, 2024
Fall 2024 Chief Physician Executive Forum
Date: Wednesday, October 23, 2024
Dr. Birx will share her extensive experience in public health and discuss current challenges and innovative solutions in healthcare, including strategies for infection control and improving patient outcomes.
“I am honored to participate in these THMA events and engage with healthcare leaders who are shaping the future of our industry,” said Dr. Deborah Birx, Chief Medical & Science Advisor at AP Sciences Group, LLC. “As we continue to face evolving challenges in public health, from infection control to antimicrobial resistance, it's crucial that we collaborate and implement together innovative solutions across all aspects of healthcare. I look forward to discussing how we can leverage emerging technologies, data-driven strategies, and interdisciplinary approaches to enhance patient care and build more resilient health systems.”
These fireside chats come on the heels of ActivePure Medical's recent announcement of a pioneering study published in the American Journal of Infection Control. The study demonstrated up to a 99% reduction in methicillin-resistant Staphylococcus aureus (MRSA) and a 70% decrease in total healthcare-associated infections (HAIs) across two hospitals using ActivePure Technology.1
Joseph P. Urso, Chief Executive Officer of AP Sciences Group, LLC, added, “Dr. Birx's participation in these prestigious THMA events provides a valuable platform to share our vision for a safer healthcare environment. Our technology's proven ability to significantly reduce HAIs and surface contamination represents a critical advancement in infection control. We are honored to contribute to these important discussions and showcase how ActivePure is shaping the future of healthcare safety.”
THMA events, including the fireside chats featuring Dr. Birx, are closed-door sessions. These events are not open to the media and will not be recorded. Discussions are designed to facilitate open and candid conversations among healthcare leaders and industry experts.
About ActivePure Medical
ActivePure Medical, a division of AP Sciences Group, LLC, is a global leader in proactive, continuous surface and air decontamination systems for healthcare. The company's proprietary ActivePure Technology, based on advanced photohydrolysis, generates powerful oxidizing molecules that safely neutralize indoor contaminants. This process replicates natural atmospheric cleansing processes, providing automated protection against environmental contamination risks. ActivePure Technology effectively reduces many common volatile organic compounds (VOCs) and operates without producing harmful ozone, making it safe for continuous use in occupied spaces. Initially developed for space exploration, it has evolved to reduce exposure to pathogens, including RNA and DNA viruses, bacteria, and molds, by up to 99.9% in the air and on surfaces. ActivePure Technology has proven effective across various settings, including acute care, long-term care facilities, and commercial buildings. ActivePure Technology is a key component in the ActivePure Medical Guardian, an FDA 510(k)-cleared Class II Medical Device. For more information, please visit ActivePure.com/healthcare.
_________________
1 Trosch, K et al. The effects of a novel, continuous disinfectant technology on methicillin-resistant Staphylococcus aureus (MRSA), fungi, and aerobic bacteria in 2 separate intensive care units in 2 different states: An experimental design with observed impact on health care associated infections (HAIs). Am. J. Infect. Control. 2024 Aug;52(8):884-892. doi:10.1016/j.ajic.2024.03.013
